sur ABIONYX (EPA:ABNX)
ABIONYX Pharma Half-Yearly Liquidity Contract Report
ABIONYX Pharma has released its half-yearly report on the liquidity contract with TP ICAP (Europe) SA. As of June 30, 2025, the liquidity account included 162,298 shares and a cash balance of €86,279.52.
In the first half of 2025, ABIONYX conducted 253 purchase transactions totaling 223,631 shares at €275,707.78. Additionally, 214,077 shares were sold through 226 transactions, generating €272,643.70.
Comparatively, on December 31, 2024, the liquidity account had 152,744 shares and €90,498.64 in cash. At the contract's initiation, available resources were 131,000 shares and €40,801.20 in cash.
This report details the liquidity contract activities between ABIONYX Pharma and TP ICAP, highlighting substantial trading volumes and financial movements over the past six months.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de ABIONYX